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Terminalia laxiflora, Terminalia brownii and Anogeissus leiocarpus are used as decoctions, 
macerations, infusions and fumigations in East and West African traditional medicine for treatment of 
infectious diseases and their symptoms. Using this ethnopharmacological information as a guideline 
for our research and owing to the fact that these species have not been subjected to in depth 
antibacterial and phytochemical studies, thirty-nine extracts of various polarities of the stem bark, 
stem wood and roots were studied for growth inhibitory effects against the human pathogenic bacteria 
Staphylococcus epidermidis, Staphylococcus aureus, Micrococcus luteus and Pseudomonas 
aeruginosa. Our results indicate that the studied species contain antibacterial compounds of a wide 
range of polarities. All polar root extracts of T. laxiflora and various polar extracts of T. brownii roots, 
including hot water decoctions, gave broad-spectrum antibacterial effects and low MIC values of 39 
µg/ml. The main ellagitannins in an ethyl acetate extract of the root of T. laxiflora were found to be 
corilagin and its derivative and punicalagin. A methanol extract of the roots of T. brownii contained 
methyl-(S)-flavogallonate and its derivative as the main identified ellagitannins. Moreover, both 
Terminalia species were found to contain ellagic acid xylopyranoside and methyl ellagic acid xyloside 
and pure ellagic acid was present in T. brownii. Pure punicalagin did not give as low MIC as an ethyl 
acetate extract of the roots of T. laxiflora, containing punicalagin as one of its main compounds, 
although this ellagitannin totally inhibited the growth of S. aureus at 125 µg/ml and P. aeruginosa at 
500 µg/ml. Similarly, pure ellagic and gallic acid gave higher MIC values than the methanolic root 
extract of T. brownii against S. aureus and P. aeruginosa. Moreover, a Sephadex LH-20 fraction of 
the methanolic extract of the roots of T. brownii, enriched with methyl-(S)-flavogallonate and its 
isomer, gave higher MIC values than the crude methanolic extract. These results suggest that the 
polyphenols in the extracts might act synergistically with each other. A methanolic soxhlet extract of 
the roots of A. leiocarpus, containing ampelopsin, aromadendrin, taxifolin,                  -
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methylpinosylvin gave a low MIC value of 39 µg/ml against all bacterial strains used in this 
investigation. Our results demonstrate that the roots, stem bark and stem wood of T. brownii, T. 
laxiflora and A. leiocarpus are rich sources of (new) antimicrobial compounds and justify the uses of 
these plants for treatment of infections in African traditional medicine.  
Keywords: Terminalia laxiflora; Terminalia brownii; Anogeissus leiocarpus; antibacterial; Africa; 
polyphenols 
Abbreviations: IZ, inhibition zone; CFU/ml, colony forming units/ml 
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1. Introduction    
Bacterial infections such as acute respiratory disorders and diarrhoea are still the number one 
cause of death among children aged under five in Sub-Saharan Africa (Mulholland and Adegbola, 
2005) and in most developing countries globally (WHO, 2003). It has been estimated that nearly half 
of all deaths in tropical countries are caused by infectious diseases (Okigbo and Ajalie, 2005). 
Antibiotic resistance has become a growing problem in Africa as in the rest of the world (Spencer, 
2007). In Africa, this resistance is aggravated by the HIV epidemic, malnutrition and inadequate 
antibiotic treatments. In the developing world, including Africa, few suitable and affordable 
conventional antibiotic therapies are available (WHO, 2003).  
Africa is a rich source of medicinal plants and depending on the country an estimated 60-80 % 
of the populations are using plants as readily available and affordable phytomedicines (Apulu et al., 
1994; Mahomoodally, 2013; Schmelzer and Gurib-Fakim, 2013). According to the World Health 
Assembly (WHA) more evidence-based research is needed to elucidate the active compounds in 
traditional phytomedicines as well as to reveal and eliminate toxic compounds. New antimicrobial 
compounds with new mechanisms of actions could be found from these phytomedicines and from 
plant species based on their ethnomedical use for treatment of infections (Cos et al., 2006). 
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Phytomedicines and compounds isolated from them could be used in combination with conventional 
antibiotics to enhance their effects as well as to counteract multi-drug resistance (MDR) (Rasoanaivo 
et al., 2011). 
The genus Terminalia (Combretaceae) is broadly distributed over the world in deciduous 
woodland and bushy grassland habitats and comprises 200 tropical and subtropical species (Foyet & 
Nana, 2013; Wickens, 1973). Thirty species of Terminalia are native to Africa (Wickens, 1973). Most 
of these species of Terminalia have some applications in African traditional medicine and many of 
them are used for the treatment of infectious diseases (Neuwinger, 2000). Species of Terminalia are a 
rich source of polyphenols, and among them ellagitannins (Avula et al., 2013; Juang et al., 2004; 
Tanaka et al., 1986). These ellagitannins are extracted in hot water decoctions used in traditional 
medicine and might be responsible for many of their beneficial health effects, including antibacterial 
properties. Polyphenolic compounds, and especially ellagitannins in African Terminalia species have 
been characterized to a rather limited extent, however (Pfundstein et al., 2010).   
Terminalia laxiflora Engl. & Diels and T. brownii Fresen are used traditionally as decoctions, 
macerations, infusions, ointments, liniments and fumigations for treating a myriad of conditions and 
diseases, including bacterial and fungal infections, cough, diarrhoea, yellow fever, wounds, skin and 
venereal diseases (Table 1). The various ways in which these two species are made into traditional 
medicinal preparations indicate that they contain a range of antimicrobial compounds belonging to 
different chemical classes. Despite the various uses in traditional medicine just a few studies have 
been conducted on the antimicrobial activities and phytochemistry of extracts of these species. 
Extracts of T. brownii were found to give promising growth inhibitory effects against sweet potato 
pathogens (Opiyo et al., 2011) and human pathogenic bacteria (Mbwambo et al., 2007) as well as 
antimycoplasmal effects (Muraina et al., 2010). Data on characterization of compounds from T. 
brownii is scarce: triterpenoids and anti-Pseudomonas ellagic acid derivatives were reported recently 
in the stem bark of T. brownii (Machumi et al., 2013). In addition, the stem bark of T. brownii has 
been reported to contain a chromone derivative, terminalianone as well as the ellagitannins 
punicalagin and terchebulin (Negishi et al., 2011; Yamauchi et al., 2016). Recently, stem wood 
extracts of T. laxiflora were demonstrated to give promising in vitro anti-acne effects (Muddathir and 
Mitsunga, 2013) and leaf extracts were found to give antimycoplasmal effects (Muraina et al., 2010). 
Moreover, extracts of the root bark of T. laxiflora were found to give good antibacterial effects 
(Fasola et al., 2013). To our knowledge only a couple of papers report on the phytochemical 
composition of T. laxiflora; Laxiflorine, a polyhydroxy-lactone, has been reported from the root bark 
and some ellagic acid derivatives from the heartwood (Ekong and Idemudia, 1967). The ellagitannins, 
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flavogallonic acid dilactone and terchebulin as well as ellagic acid were found to be present in stem 
wood extracts (Muddathir et al., 2013).  
The genus Anogeissus comprises fourteen species in Africa (Rogers and Verotta, 1996; Eloff, 
1999). In Sudan the genus is represented by one species, Anogeissus leiocarpus (DC.) Guill. & Perr, 
[previously known as Conocarpus leiocarpus DC., Prodr. (1828) and Anogeissus schimperi Hochst. 
ex Hutch. & Dalziel (1927)] (El Amin, 1990; El Ghazali et al., 2003). A. leiocarpus, also known as the 
chewing stick or axlewood tree (Ndjonka et al., 2014; Salau et al., 2013), has a long history of 
traditional uses in Africa for treatment of a broad range of ailments. Roots, leaves, stem bark and 
twigs are used for treatment of gonorrhoea, cough, wounds, acute respiratory tract infections, stomach 
infections, fever and tuberculosis as well as parasitic diseases, among other uses (Table 1). The 
Yoruba people in Nigeria use A. leiocarpus to treat bacterial infections in general, and both roots and 
twigs are used as chewing sticks for dental hygiene (Dweek, 1996). A. leiocarpus is used externally as 
decoctions and fumigations for treatment of skin diseases and internally as hot water decoctions and 
infusions for the treatment of cough (Dweek, 1996). In agreement with these traditional uses, the 
extracts of the stem bark, roots, fruits and leaves of A. leiocarpus have been found to exert growth 
inhibitory effects against various human pathogenic bacteria, yeasts and fungi (Akande and Hayashi, 
1998; Batawila et al., 2005; Elegami et al., 2002; Koné and Atindehou, 2008; Kubmarawa et al., 2007; 
Mann et al., 2008 a, b, c; Mann et al., 2010; Mann, 2012; Ogundiya et al., 2006; Rajpoot and Singh, 
2014; Sanogo et al., 1998; Taiwo et al., 1999). Flavonoids, ellagitannins, ellagic acid derivatives, 
triterpenoids and alkaloids are known from A. leiocarpus (Attioua et al., 2011; Hubert et al., 2014; 
Kubmarawa et al., 2007; Ndjonka et al., 2014; Rajpoot and Singh, 2014; Shuaibu et al., 2008). The 
roots of A. leiocarpus have, however, to the best of our knowledge not been investigated in detail for 
their ellagitannins, flavonoids and other compounds, although Salau et al. (2013) have made a general 
screening of compound classes in the root bark, and reported the presence of tannins, flavonoids, 
alkaloids, saponins, phlobatannins and terpenes. To date three ellagitannins, castalagin, punicalagin 
and terchebulin are known from the stem bark of A. leiocarpus (Shuaibu et al., 2008).  
In this investigation, using an ethnomedicinal approach and in an attempt to find extracts with 
good antibacterial potential, thirty-nine extracts of various polarities of T. brownii, T. laxiflora and A. 
leiocarpus roots, stem bark and stem wood were screened for antibacterial effects against 
Staphylococcus aureus ATCC 25923, S. epidermidis ATCC 12228, Micrococcus luteus ATCC 4698 
and Pseudomonas aeruginosa ATCC 27853. Our study focused especially on the antibacterial effects 
and chemical composition of the roots of the studied plants, since to the best of our knowledge, there 
exists only a few studies in this respect. Likewise, A. leiocarpus stem wood and T. laxiflora root 
extracts have not been screened against M. luteus, S. aureus and S. epidermidis. Some of the extracts 
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were prepared as hot water decoctions to imitate traditional medicinal preparations. Extracts giving 
especially promising antibacterial effects, such as an ethyl acetate extract of the stem bark of A. 
leiocarpus, methanolic soxhlet root extracts of A. leiocarpus and T. brownii as well as an ethyl acetate 
extract of T. laxiflora roots were selected for HPLC-DAD and UHPLC/Q-TOF MS analysis with 
emphasis on their ellagitannin and flavonoid composition. For the first time, [M-H]
- 
data, UV max 
and HPLC retention times of various phenolic compounds as well as HPLC fingerprints of T. brownii, 
T. laxiflora and A. leiocarpus extracts are presented.  
 
2. Materials and Methods 
 
2.1. Plant material collection 
Stem wood, stem bark and roots of the plants used in this study were collected in May to June 
2006 and in August 2012 from El Nour Natural Forest Reserve, southeast of Ed Damazin, Sudan 
(Table 1). The plants were collected by the first author and Mr. Gibreel H. (PhD) and identified at the 
Faculty of Forestry, University of Khartoum, Sudan. Voucher specimens are deposited at the Faculty 
of Forestry and Faculty of Sciences, University of Khartoum, Sudan.  
 
2.2. Soxhlet extraction, sequential extraction and solvent partition 
Samples of roots and stem logs of the diameter 20-42 cm from healthy trees were collected. 
Root, stem wood and stem bark were dried and cut into small chips using a sawing machine followed 
by a hammer mill (mesh.) to obtain finely ground samples.  
Soxhlet extraction was performed in order to obtain crude methanolic extracts. 20 g of plant 
powder was added to a soxhlet sock and 500 ml of methanol (MeOH) was poured into a soxhlet flask. 
The soxhlet extraction continued for five hours whereafter the extract was dried in vacuo in a 
Rotavapor machine (Heidolph VV2000) and freeze-dried in a lyophilizer for two days. 
Sequential extraction was performed using 100 g of the powdered dry plant material and 
solvents of increasing polarities. Initially, the plant material was extracted using 1600 ml petroleum 
ether (PE), followed by extraction with 1400 ml chloroform (CHCl3). The residue was then extracted 
with 80 % methanol for all other plant parts except for the root part for which marc was extracted with 
acetone before adding 80 % methanol. The 80 % methanol extract was further fractionated by solvent 
partition using ethyl acetate (EtOAc) in order to obtain ethyl acetate and aqueous fractions. The 
filtered extracts were concentrated to dryness in vacuo using a Rotavapor machine (Heidolph 
VV2000) and then freeze-dried for two days in a lyophilizer. 
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Decoctions were made according to a procedure used by traditional healers in Sudan: 20 g 
plant powder was mixed with water (500 ml) which was brought to boil. The decoction was 
centrifuged at 2000 rpm for 10-15 minutes (Eppendorf AG centrifuge 5810R, Germany) and filtered 
using filter paper (Schleicher & Schuell,  150 mm, Germany) whereafter it was freeze-dried for two 
days. 
All the freeze-dried extracts were dissolved in methanol to give a final concentration of 50 
mg/ml. These stock solutions were used for initial antibacterial screening using an agar disk diffusion 
method. 
 
2.3. Sephadex LH-20 chromatography 
A root methanolic soxhlet extract of Terminalia brownii was subjected to Sephadex LH-20 
(Pharmacia, Uppsala, Sweden) fractionation according to Ann Hagerman, Tannin handbook 
(Hagerman, 2011). 200 mg dry root methanolic soxhlet extract was dissolved in 10 ml of 80% (v/v) 
EtOH. The extract was centrifuged whereafter it was poured into a 50 ml volume plastic centrifuge 
tube (Eppendorf) containing 2.5 g Sephadex LH-20. The Sephadex LH-20 and the extract in the tube 
were mixed carefully, centrifuged at 3000 rpm for 3 min, whereafter the supernatant was collected. 
Extractions using 8-10 ml 80% (v/v) EtOH and centrifugations were repeated several times until the 
resulting supernatant changed color from yellow to colourless and showed an absorbance close to zero 
at 280 nm. The supernatant (EtOH wash) was collected into a rotary evaporator flask. The tannin 
fraction (acetone wash) was released from the Sephadex LH-20 using 2  15 ml 70% acetone. The 
acetone wash was filtrated using double filter paper into a 100 ml rotary evaporation flask to be and 
concentrated to dryness using a rotary evaporator. The 80 % EtOH wash was also reduced to dryness 
using a rotary evaporator. The acetone and EtOH washes were dissolved in 5 ml H2O before dried 
using liquid nitrogen, whereafter they were freeze-dried for two days. The freeze-dried fractions were 




Summary of traditional uses of Terminalia laxiflora, T. brownii and Anogeissus leiocarpus collected in Sudan in 2006 and 2012. Vernacular names according to arabic 
language and local dialects in Sudan. Voucher numbers refer to deposits at University of Khartoum, Sudan.  
Plant botanical name Voucher No. Vernacular 
name 
Plant parts used Traditional uses References 
Terminalia laxiflora 
Engl. & Diels. 








malaria, cough, bronchitis, back pains, 
venereal inflammations, bacterial 
infections, fever, skin pustules, wounds 
and hemostatic hemorrhoids, rheumatism, 
eye diseases, anti-inflammatory, tonic and 
skin diseases, diarrhoea, dysentery, 
jaundice, diuretic. 
Doka and Yagi, 2009; El Ghazali et al., 
1987; El Ghazali et al., 1997; El Ghazali et 
al., 2003; Fasola et al., 2013; Foyet & 
Nana 2013; Haxaire, 1979; Koné and 
Atindehou, 2008; Muddathir et al., 2013; 
Musa et al., 2011; Neuwinger, 2000; Salih, 
personal communication.  
Terminalia brownii 
Fresen 





malaria, cough, bronchitis, back pain, 
venereal diseases, bacterial infections, 
fever, skin pustules, wounds and 
hemostatic hemorrhoids, allergy, gastric 
ulcers, stomach ache, rheumatism, 
diarrhoea, anti-inflammatory, tonic, chest 
coughs, skin diseases, diabetes, allergy, 
family planning, worms, kidney disorders, 
yellow fever. 
Abd alla et al., 2013; Doka and Yagi, 
2009; El Ghazali et al., 1997; El Ghazali et 
al., 2003; Kareru et al., 2007, 2008; Keter 
and Mutiso, 2012; Machumi et al., 2013; 
Mariod et al., 2014; Mbwambo et al., 
2007; Mosango, 2013; Musa et al., 2011; 
Muthee et al., 2011; Neuwinger, 2000. 
Salih, personal communication. 
  
Anogeissus leiocarpus 
(DC.) Guill. & Perr. 




Anti-inflammatory, dysentery, cough, 
tuberculosis, giardiasis, malaria, 
trypanosomiasis, yellow fever, vermifuge, 
jaundice, pathogenic microbial infections, 
gonorrhea, wounds. 
Akanbi et al., 2014; Batawila et al., 2005; 
Elegami et al., 2002; El Ghazali et al., 
2003; Mann et al., 2008 a, b, c; Mann, 
2012; Mann et al., 2014; Muraina et al., 
2010; Musa et al., 2011; Ndjonka et al., 
2012; Ndjonka et al., 2013. Okpekon et al., 
2004; Taiwo et al., 1999; Rajpooth & 
Singh, 2014; Gbadamosi & Ogunsuyi, 




2.4. High performance liquid chromatography (HPLC-UV/DAD) and mass spectrometry (UHPLC/ Q-
TOF MS)  
 
2.4.1. HPLC-UV/DAD method 
HPLC analysis was performed using a method described by Julkunen-Tiitto and Sorsa (2001), 
developed for detection of polyphenols. The liquid chromatographic system consisted of a Waters 600 
E pump and a controller coupled to a 991 PDA detector. An autosampler controlled by Agilent 
Chemstation software (Water Corp., Milford, USA) was used. Separations were performed on a 
reversed phase Hypersil Rp C18 column (length: 10 mm; ID: 2 mm). 10 μl of samples (2 mg/ml in 
50% MeOH) were injected. Gradient elution was performed at a flow rate of 2 ml/min using two 
solvent systems: A) Aqueous 1.5% tetrahydrofuran + 0.25% orthophosphoric acid and B) 100 % 
MeOH. UV fingerprint chromatograms were constructed at 220, 270, 280, 320 and 360 nm. UVλ 
absorption maxima spectra of the compounds of interest were recorded between 200 and 400 nm 
using Agilent Chemstation software. Compounds of interest were compared to commercial 
compounds and literature (Conrad et al., 2001; Pfundstein et al., 2010). 
 
2.4.2. UHPLC/ Q-TOF MS method 
The compounds were identified using UHPLC-DAD (Model 1200 Agilent Technologies)-
JETSTREAM/QTOFMS (Model 6340 Agilent Technologies) equipped with a 2.1 x 60 mm, 1.7 µm 
C18 column (Agilent technologies) as described in Taulavuori et al. (2013). Shortly, the solvent A was 
1.5% tetrahydrofuran and 0.25% acetic acid in HPLC quality water and the solvent B was 100% 
methanol. A gradient run was as follows: from 0 to 1.5 min, B 0 %, from 1.5 to 3 min, 0 to 15% B, 
from 3 to 6 min, 10 to 30 % B, from 6 to 12 min, 30 to 50% B, from 12 to 20 min, 50 to 100%, and 
from 20 to 22 min, 100 to 0% B. The mass spectra were acquired at positive and negative ion mode 
depending on the compounds and the mass range was from 100 to 2000 m/z. 
 
2.5. Bacterial strains and assays used for screening antibacterial activity 
 
2.5.1. Bacterial strains 
The growth inhibitory activity of the stem wood, stem bark and root extracts of Terminalia 
laxiflora, Anogeissus leiocarpus and Terminalia brownii were investigated against four bacterial 
strains. Three Gram-positive and one Gram-negative strain were used; Staphylococcus aureus ATCC 
25923, Staphylococcus epidermidis ATCC 12228, Micrococcus luteus ATCC 4698 and Pseudomonas 
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aeruginosa ATCC 27853. All strains were obtained from the Faculty of Pharmacy, Division of 
Pharmaceutical Biosciences, University of Helsinki, Finland. 
 
2.5.2. Standard antibiotics and pure compounds 
Penicillin-G (Fluka, Germany), gentamycin (Sigma-Aldrich, St. Louis MO, USA), tetracycline 
hydrochloride (Sigma-Aldrich, St. Louis MO, USA) and ampicillin (Sigma-Aldrich, St. Louis MO, 
USA) were used as standard antibiotics. Punicalagin (CAS 65995-63-3 from pomegranate, Sigma-
Aldrich, Germany), ellagic acid (E-2250 from chestnut bark, Sigma-Aldrich, England) and gallic acid 
(G-7384, Sigma-Aldrich, China) were used as pure compounds. 
 
2.5.3. Agar disk diffusion method 
Extracts of the roots, stem bark and stem wood of Terminalia laxiflora, Anogeissus leiocarpus 
and Terminalia brownii were screened for their antibacterial effects using an agar disk diffusion 
method for initial screening (Fyhrquist et al., 2002; Rauha et al., 2000). Extracts and antibiotics were 
dissolved in methanol to obtain stock solutions of 50 and 10 mg/ml, respectively. Tetracycline, 
penicillin-G, ampicillin and gentamicin were used as positive controls. 
Twenty-five ml of sterile base agar (Difco, VWR Finland) as bottom layer and twenty-five ml of 
isosensitest agar (OXOID, Thermo Fisher Scientific), as top layer were applied into sterile petri dishes 
( = 14 cm, VWR Finland). To initiate a test, nutrient agar slants were inoculated with bacteria and 
gr w    er  ght  t 37˚C. Act  e   gr w  g bacterial culture from the test tube was transferred into 
isotonic sodium chloride, whereafter the absorbance of the bacterial suspension was measured 
spectrophotometrically at 625 nm (UV-Visible Spectrophotometer, Pharmacia LKB-Biochrom 4060). 
Suspensions were diluted with 0.9 % (w/v) sodium chloride to an absorbance of 0.1 at 625 nm, 
corresponding to approximately 1 × 10
8
 CFU/ ml. 200 µl of this suspension was spread evenly on 
each petri dish. Whatman filter paper discs ( = 12.7 mm, Scleicher & Shuell) containing 200 µl of 
50 mg/ml extracts and 10 mg/ml antibiotics, respectively, were placed equidistantly on the agar 
surface. 200 µl methanol was pipetted on some filter papers as solvent control. The plates were 
  cub te   t + ˚C f r 1 h  r  r t    cub t      er  ght  t +37˚C. The    meter  f   h b t    z  e  
were measured and expressed as the mean of four diameters ± SEM. 
For extracts which builded up excess precipitation, reliable minimum inhibitory concentration 
(MIC) could not be estimated using the turbidimetric microdilution method and therefore approximate 
MIC values were determined using agar diffusion. For MIC estimations, 200 µl of two-fold dilutions 
of the extracts and antibiotics from 5 mg/ml to 39 µg/ml and from 1 mg/ml to 0.0076 µg/ml, 
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respectively, were pipetted onto Whatman filter papers ( = 12.7 mm). The approximate MIC was 
estimated as the lowest mean inhibitory concentration of three tests (triplicates)  SEM that gave a 
clear zone of inhibition (radius of IZ measured from the edge of the filter paper disc was not more 
than 1 mm)  r u   the f  ter   er    c  fter   cub t     t +37˚C f r 2  h. 
 
2.5.4. Microdilution method  
 
A microdilution turbidimetric broth method based on the guidelines of Clinical and Laboratory 
Standards Institute (2012) was used for determination of MIC (Minimum inhibitory concentration) of 
the most promising extracts selected from agar diffusion screening results. Extracts (50 mg/ml) were 
dissolved in methanol and two-fold serially diluted in Mueller Hinton Broth (Becton, Dickinson & 
Company, USA) in sterile Eppendorf tubes from 5 mg/ml to 19.53 µg/ml. A Sephadex LH-20 ethanol 
fraction of T. brownii roots was two-fold serially diluted from 3 mg/ml (in 10% v/v MeOH) to 11.72 
µg/ml using Mueller Hinton broth. Ellagic acid, gallic acid and punicalagin were prepared as 1 mg/ml 
stock solutions in 10% (v/v) dimethyl sulfoxide (DMSO, Sigma-Aldrich, France) and two-fold 
serially diluted with broth until a concentration of 31.25 µg/ml was reached. Tetracycline, penicillin, 
ampicillin and gentamicin were used as positive controls from 1 mg/ml to 0.0076 µg/ml. 100 µl of the 
dilutions were pipetted onto a 96 well microtitre plate (Nunc, Nunclone, Denmark). Methanol and 
DMSO were used as solvent controls, and were found not to affect the growth of the bacteria at the 
concentrations used in the tests (5 % v/v or less). All bacterial cultures were grown overnight either in 
Mue  er H  t   br th  r    Nutr e t  g r     t   t +37˚C bef re the te t. 1 m   f Mue  er H  t   
bacterial suspension or inoculum transferred from nutrient agar slant to 0.9% (w/v) sodium chloride 
were measured for turbidity at 625 nm using a UV-Visible Spectrophotometer type 1510 (Thermo 
Fisher Scientific Oy) and were diluted to an absorbance of 0.1 (approximately 1.0 × 10
8
 CFU/ ml). 
The bacterial suspensions were diluted further so that the final number of cells in the inoculum was 
1.0 × 10
6
 CFU/ml. A portion of 100 µl of this inoculum was added to the wells of the microplate 
(Nunc, Nunclone, Denmark) together with 100 µl extracts, fractions, pure compounds or antibiotics, 
the wells thus containing 5 × 10
5
 CFU/ml. The microplates were incubated for 24 h at +37˚C, 
whereafter the turbidity of the wells at 620 nm was recorded using Victor 1420 (Wallac, Finland) 
spectrophotometer. All assays were done in quadruplicate and the % inhibition of growth results were 
expressed as mean ± standard error of mean (SEM). The minimum inhibitory concentration (MIC) 
was estimated as the lowest concentration that inhibited 90 % or more of the growth of the studied 




2.6. Statistical analysis of data 
All data (diameters of inhibition and percentage inhibition of growth) were expressed as mean ± SEM, 
obtained from three-four independent experiments, each performed in duplicate, triplicate or 
quadruplicate. 
 
3. Results and discussion 
 
3.1. Antibacterial results 
Thirty-nine extracts of various polarities, including decoctions of the roots, stem bark and stem wood 
of the traditional medicinal plant species Terminalia laxiflora, T. brownii and Anogeissus leiocarpus  
were screened for their antibacterial effects (Table 2 and 3). The plant species were chosen according 
to their reported uses for treatment of bacterial infections in African traditional medicine (Table 1) and 
due to the fact that these species only to a limited extent have been investigated for their antimicrobial 
effects and compounds especially when it comes to the root part. Clinically relevant human 
pathogenic bacteria were used for the screenings. Of these bacteria, especially Staphylococcus aureus 
and Pseudomonas aeruginosa are known for their ability to develop antibiotic resistance. Suitable 
treatment regimens against multi-drug resistant S. aureus have been narrowed to just a few agents, 
among them the aminoglycoside vancomycin (Appelbaum, 2006; Mwangi et al., 2007). P. aeruginosa 
has been reported to develop resistance to multiple classes of antibiotics (Poole, 2011) and easily 
develops antibiotic resistance due to several efflux pump systems in the membranes (Li et al., 1994) as 
well as due to its ability to form biofilms during pathogenesis (Rasamiravaka et al., 2014). Our results 
demonstrate that T. laxiflora, T. brownii and A. leiocarpus contain compounds that strongly reduce the 
growth of S. aureus and P. aeruginosa, and that some extracts were more effective growth inhibitors 
than conventional antibiotics. 
 
3.1.1. Terminalia laxiflora  
We report for the first time that extracts of the root, stem bark and stem wood of T. laxiflora 
give promising antibacterial effects against S. aureus, S. epidermidis and M. luteus (Tables 2 and 3). 
 
Root extracts 
The most outstanding growth inhibitory effects in terms of minimum inhibitory concentration 
were obtained by all the investigated polar root extracts of T. laxiflora, giving low MIC values of 
39.06 µg/ml against all bacterial strains in this screening (Table 3). We found that our MIC values 
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correlated well with our agar diffusion results, as all root extracts giving low MIC values also 
demonstrated large inhibition zones (Table 2). Interestingly, a hot water decoction made according to 
guidelines of traditional healers in Africa gave promising growth inhibitory effects against all 
bacterial species (IZ: 24-39 mm, MIC 39.06 – 78.12 µg/ml) (Table 2) and the effects were dose-
dependent against M. luteus (Fig. 6). Our results are in agreement with one previous investigation in 
which root bark extracts of T. laxiflora were reported to show good antibacterial effects against P. 
aeruginosa (Fasola et al., 2013). Fasola et al. (2013) did not include S. aureus and S. epidermidis in 
their investigation and therefore our results now indicate that the root of T. laxiflora contains 
compounds active against Staphylococci as well. In summary our results on the good antibacterial 
effects of T. laxiflora root extracts and decoction support the traditional medicinal uses of the roots 
and root bark of this plant for diarrhoea and wounds (Fasola et al., 2013; Foyet & Nana, 2013) since 
P. aeruginosa and S. aureus are often present in chronic wounds (Serra et al., 2015) and S. aureus can 
be a causative agent of diarrhoea (Kadariya et al., 2014). 
We hypothesize that the ellagic acid derivatives, punicalagin and gallic acid present in the ethyl 
acetate extract of T. laxiflora roots (Table 4) contribute to its significant antibacterial effects, since 
related compounds from the root of T. macroptera have confirmed efficiency against clininal strains 
of Gram-negative bacteria (Silva et al., 2012). Notably, we found that the ethyl acetate extract of the 
roots of T. laxiflora was a more effective growth inhibitor than tetracycline and gentamycine against 
P. aeruginosa (Table 3), and this activity is suggested to be due partly to punicalagin which we found 
in high concentrations in this extract (12.9 % peak area, Table 4). Reddy et al. (2007) found that 
punicalagin inhibited the growth of P. aeruginosa at a very low IC50 concentration of 3.2 µM (equal 
to 1.8 µg/ml). In contrast to their results, however, we found that the MIC value of punicalagin was 
125 µg/ml against S. aureus and 500 µg/ml against P. aeruginosa. Moreover, these MIC values were 
significantly higher than our MIC of 39 µg/ml for the crude ethyl acetate extract (Table 3). This might 
be due to synergistic effects between the compounds in the extract, or due to some unkown and very 
powerful antibacterial compound present in the extract. Our results on MIC values of punicalagin are 







Table 2  
Antimicrobial activities of extracts of stem wood, stem bark and roots of Terminalia laxiflora, T. brownii and Anogeissus 
leiocarpus. Results obtained with an agar diffusion method.  
Extracts and antibiotics M. luteus S. aureus S. epidermidis P. aeruginosa 
T. laxiflora (S.W.): 
    
Pt  NT NT 23 ± 0.29 NT 
CHCl3 21 ± 0.10 18 ± 0.33 18 ± 0.17 32 ± 0.00 
EtOAc 26 ± 0.20 23 ± 0.41 22 ± 0.50 21 ± 0.50 
Aqueous 25 ± 0.10 21 ± 0.41 20 ± 0.33 19 ± 0.44 
MeSox 26 ± 0.33 19 ± 0.00 18 ± 0.33 17 ± 0.33 
T. laxiflora (S.B.): 
    
Pt 19 ± 0.10 NT 22 ± 0.33 17 ± 0.17 
CHCl3 23 ± 0.00 16 ± 0.44 21 ± 0.17 17 ± 0.17 
EtOAc 27 ± 0.33 20 ± 0.30 20 ± 0.33 21 ± 0.33 
Aqueous 19 ± 0.10 15 ± 0.00 20 ± 0.33 18 ± 0.10 
MeSox 22 ± 0.33 21 ± 0.33 19 ± 0.33 23 ± 0.33 
T. laxiflora (R): 
    
HH2O 39 ± 0.33 25 ± 0.33 24 ± 0.17 25 ± 0.29  
MeSox 39 ± 0.29 22 ± 0.00 22 ± 0.00 25 ± 0.17 
acetone 36 ± 0.17 22 ± 0.33 22 ± 0.17 21 ± 0.17 
EtOAc 37 ± 0.00 21 ± 0.17 20 ± 0.17 22 ± 0.17 
T. brownii (S.W.): 
    
CHCl3 18 ± 0.30 19 ± 0.16 NT 18 ± 0.29 
EtOAc 24 ± 0.30 20 ± 0.16 17 ± 0.29 18 ± 0.29 
MeSox 26 ± 0.33 20 ± 0.30 19 ± 0.00 16 ± 0.33 
T. brownii (S.B.): 
    
CHCl3 20 ± 0.03 18 ± 0.44 21 ± 0.17 16 ± 0.29 
EtOAc 22 ± 0.40 17 ± 0.33 20 ± 0.17 26 ± 0.50 
Aqueous 19 ± 0.30 20 ± 0.44 22 ± 0.50 16 ± 0.29 
MeSox 24 ± 0.30 21 ± 0.30 19 ± 0.20 19 ± 0.33 
T. brownii (R): 
    
HH2O 37 ± 0.00 21 ± 0.17 20 ± 0.17 22 ± 0.17 
MeSox 39 ± 0.17 22 ± 0.00 21 ± 0.17 22 ± 0.29 
acetone 39 ± 0.00 23 ± 0.17 22 ± 0.00 20 ± 0.29 
EtOAc 38 ± 0.00 20 ± 0.17 19 ± 0.00 20 ± 0.44 
A. leiocarpus (S.W.): 
    
Pt NT NT 30 ± 0.17 15 ± 0.20 
CHCl3 16 ± 0.20 15 ± 0.50 18 ± 0.17 28 ± 0.00 
EtOAc NT 19 ± 0.33 NT NT 
Aqueous 24 ± 0.10 21 ± 0.33 23 ± 0.29 21 ± 0.10 






Table 2  
Continued. 
    
Extracts and antibiotics M. luteus S. aureus S. epidermidis P. aeruginosa 
A. leiocarpus (S.B.)     
Pt NT NT NT 16 ± 0.03 
CHCl3 17 ± 0.20 17 ± 0.33 19 ± 0.17 24 ± 0.29 
EtOAc 28 ± 0.30 19 ± 0.33 23 ± 0.29 22 ± 0.22 
Aqueous 26 ± 0.33 19 ± 0.33 24 ± 0.17 21 ± 0.44 
MeSox 30 ± 0.33 24 ± 0.00 22 ± 0.30 25 ± 0.30 
A. leiocarpus (R): 
    
HH2O 32 ± 0.33 16 ± 0.00 18 ± 0.17 24 ± 0.17 
MeSox 36 ± 0.17 23 ± 0.17 28 ± 0.29 24 ± 0.44 
acetone 36 ± 0.33 22 ± 0.20 23 ± 0.29 25 ± 0.29 
EtOAc 36 ± 0.00 22 ± 0.17 23 ± 0.00 24 ± 0.29 
Antibiotics:  
    
Ampicillin 68 ± 0.02 64 ± 0.00 58 ± 0.00 NT 
Gentamicin NT 31 ± 0.03 45 ± 0.03 28 ± 0.03 
Tetracycline 53 ± 0.01 53 ± 0.02 67 ± 0.02 33 ± 0.01 
Penicillin 65 ± 0.00 68 ± 0.01 NT NT 
Diameters of inhibition in mm. Filter paper size: 12.7 mm. Two-hundred microliters of extracts (50 mg/ml) and antibiotics (10 mg/ml) were applied on 
the filter papers. Pt: Petroleum ether extracts; CHCl3; Chloroform extracts; EtOAc: ethyl acetate extracts; Aqueous: 80 % aqueous methanol; HH2O: hot 
water decoction; MeSox: methanolic soxhlet extract; S.W.: Stem wood; S.B.: stem bark; R: roots; NT: not tested. Results expressed as the mean ± SEM 
of quadruplicates. Good results indicated in bold font (Ø ˃ 20 mm) and exceptionally good activity (Ø  30 mm) underlined.  
 
We found that corilagin and its isomer are present in high concentrations in the T. laxiflora ethyl 
acetate root extract (6.7 and 20.4 % peak area, respectively, Table 4). Corilagin has been found to 
re uce the MIC  f β-lactams, such as oxallicin, in methicillin-resistant S. aureus (MRSA) by 
 u  re    g β   ct m  e  r  uct       we      re uc  g the  r  uct    of penicillin binding protein 2´ 
(Shimizu et al., 2001; Shiota et al., 2004). Corilagin has also been shown to possess good growth 
inhibitory effects against Helicobacter pylorii (Funatogawa et al., 2004) and against Staphylococcus 
aureus (Burapadaja & Bunchoo, 1995). Therefore it is certain that corilagin and its isomer contribute 
to the antibacterial effects against S. aureus we have seen for the T. laxiflora root extract. 
The growth inhibitory activity of ellagitannins and tannin-related compounds against 
microorganisms varies according to their chemical structure, and has mainly been associated to their 
protein binding capacity (Goel et al., 2005), but recently also more specific mechanisms have been 
suggested to be involved (Eloff et al., 2008). For example, ellagitannins have been thought to act as 
Lipid A agonists, mimicking LPS/Lipid A activity, and therefore there are prospects to redesign ET 
structure to function as a Lipid A antagonist by binding competitively to LPS and hindering release of 
TNF-α causing bacterial induced sepsis (Coca et al., 2009). Dimeric ellagitannin analogues have 
showed low toxicity, good bioavailability and promising antagonistic action and might therefore 
represent interesting leads for further development of anti-sepsis therapies (Feldman et al., 2002). This 
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opens prospects for finding new antimicrobial compounds among the highly variable ellagitannins in 
the largely unexplored African species of Terminalia, in which yet new structures of ellagitannins are 
to be discovered. Interestingly, we have found that the mentioned ellagitannins corilagin and its 
derivative as well as punicalagin are present in high concentrations also in hot water decoctions of the 
roots of T. laxiflora, thus supposedly being the principal antimicrobial agents in these traditional 
medicinal preparations and supporting their use for treatment of infections, and especially infections 
related to wounds, “itchy eyes” and diarrhoea (Foyet & Nana, 2013). Studies on antibiotic agent 
modifying effects of ellagitannins (and other compounds) from T. laxiflora in combinations with 
various antibiotics should be taken into consideration since combining conventional antibiotics with 
adjuvant therapy has been found to be an effective strategy for overcoming drug resistance in resistant 
bacteria and a strategy to reuse antibiotics against which bacteria have evolved resistance (Shiota et 
al., 2004). 
 
Stem bark and wood extracts 
We found that various stem bark extracts of T. laxiflora gave promising antibacterial effects 
(Table 2 and Table 3). The highest activity was recorded for an ethyl acetate extract which gave a 
MIC of 39.06 µg/ml against P. aeruginosa and was more efficient than gentamycin (MIC 62.5 µg/ml) 
and tetracycline (MIC 125 µg/ml) against this bacterial strain (Table 3). Moreover, a methanolic 
soxhlet extract gave a low MIC value of 78.12 µg/ml against all Gram-positive bacteria. These results 
illustrate the need to explore T. laxiflora stem bark ethyl acetate and methanolic soxhlet extracts for 
antimicrobial compounds. 
In terms of MIC we found that stem wood extracts of T. laxiflora were in general slightly less 
antibacterial than the stem bark and root extracts, although good antibacterial effects were 
demonstrated by some extracts of the stem wood such as ethyl acetate and methanolic soxhlet extracts 
(Table 3). The growth inhibitory effects of an ethyl acetate extract of the stem wood was dose-
dependent against S. aureus (Fig. 7). Muddathir et al. (2013) demonstrated that a methanolic stem 
wood extract of T. laxiflora, as well as terchebulin and gallic acid isolated from this extract, possess 
strong antibacterial effects against Propionibacterium acnes (Muddathir et al., 2013), but the growth 
inhibitory effects of T. laxiflora wood extracts have not been explored earlier against S. aureus and P. 
aeruginosa. In our analysis, gallic acid gave rather high MIC values against S. aureus and P. 
aeruginosa, 500 and 250 µg/ml, respectively (Table 3). These results are in accordance with Taguri et 
al., (2006). Therefore we suggest that the good antibacterial effects of the stem wood methanol and 
ethyl acetate extracts of T. laxiflora against S. aureus and P. aeruginosa, giving MIC values of 78 and 
16 
 
156 µg/ml, respectively, might be due to a combination effect of the ellagitannins and gallic acid in 
the extracts. 
Interestingly, a chloroform extract of the stem wood gave strong activity against P. aeruginosa 
expressed by large inhibition zones (IZ: 32 mm) and a petroleum ether extract gave good effects 
against S. epidermidis (IZ: 23 mm) (Table 2). This indicates that T. laxiflora stem wood also contains 
more nonpolar antimicrobial compounds to be explored. 
Our results support the uses of decoctions and other applications such as powders of T. laxiflora 
stem bark and wood for treatment of wounds, bacterial infections and their symptoms such as 
diarrhoea and cough in African traditional medicine (Batawila et al., 2005; Foyet & Nana, 2013; 
Haxaire, 1979; Musa et al., 2011; Neuwinger, 2000). Our research, together with other authors, shows 
that T. laxiflora contains a variety of antimicrobial compounds of different polarities which should be 
studied more in depth. There could be a possibility to find new antibiotic molecular structures from 
this plant. 
 
3.1.2. Terminalia brownii 
We found that most of the investigated extracts of different polarities of the roots, stem bark and 
stem wood of T. brownii were antibacterially active, although the extent of activity differed between 
organs and extracts (Table 2 and 3). In general the polar extracts were more active, but good activities 
were also expressed with a chloroform extract of the stem wood indicating that T. brownii contains a 




Methanolic soxhlet extracts of the roots of T. brownii gave the most promising antibacterial 
effects of all tested organs and extracts expressing MIC values of 39.06 µg/ml against all bacteria 
(Table 3) and inhibition zones of 39 mm against M. luteus (Table 2). This result is in accordance with 
Mbwambo et al. (2007) who also found that root extracts of this plant were more antibacterial than 
extracts of stem bark and wood. We found that a methanolic soxhlet extract and a hot water decoction 
of the roots demonstrated substantial activity against P. aeruginosa being more effective than 
gentamycin and tetracyclin (Table 3). This result is especially interesting since P. aeruginosa is 
known for its high intrinsical resistance against antibiotics and its resistance to multiple classes of 
antibiotics is increasing (Poole, 2011). In HIV-infected persons, Pseudomonas can cause severe 
pneumonia and often leads to a necrotizing infection responding poorly to antibiotic treatment 
(Roilides et al., 1992). 
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We found that the methanolic soxhlet extract of T.brownii roots is rich in ellagitannins, among 
them methyl-(S)-flavogallonate and its derivative, as well as various ellagic acid derivatives (Fig. 2, 
Table 4). The promising antibacterial effects expressed by this extract could therefore be due to 
ellagitannins. In an attempt to separate ellagitannin enriched fractions from this highly antibacterial 
extract, we performed Sephadex LH-20 fractionation. The resulting ethanol wash, enriched with 
methyl-S-flavogallonate and its isomer was obtained. This fraction, however, gave a higher MIC value 
than the crude extract against S. aureus and P. aeruginosa (Table 3). This result shows a trend similar 
to that of the pure phenols and polyphenols (gallic acid, ellagic acid and punicalagin) compared to 
crude extracts of Terminalia, so that in the extracts these compounds seem to be more antibacterial 
than separately (Table 3). 
Part of the prospective antibacterial effects of the methanolic soxhlet root extract of T. brownii 
might be due to ellagic acid, which was present in high concentrations (10.82 % peak area)  in the 
extract along with ellagic acid glycosides (Fig. 2, Table 4). We found that pure ellagic acid exerted 
less antibacterial activity (MIC 125 and 250 µg/ml against S. aureus and P. aeruginosa, respectively) 
than the crude extract (MIC 39 µg/ml) (Table 3). In contrast to our results on the antibacterial activity 
of ellagic acid, Machumi et al. (2013) found that ellagic acid derivatives in the stem bark of T. 
brownii, such as di-galloyl-rhamnopyranosyl ellagic acid and diellagic lactone gave very good growth 
inhibitory effects against P. aeruginosa, demonstrating as low IC50 values as 8.8 and 8.4 µg/ml, 
respectively. Thus, it is possible that the sugar part in glycosidic ellagic acid derivatives as well as 
galloyl-groups are important for their antibacterial activity. This warrants further studies in the 
antibacterial activities of ellagic acid glycosides and other ellagic acid derivatives isolated from the 
root part of T. brownii, both in combinations and separately. Moreover, ellagic acid derivatives have 
also been demonstrated to have indirect antibacterial effects and ellagic acid derivatives from a fruit 
extract of Terminalia bellerica were found to inhibit quorum sensing (QS) of P. aeruginosa (Sarabhai 
et al., 2013). In this same publication, Sarabhai et al. (2013) found that pure ellagic acid did not exert 
much biofilm inhibiting effect, but most of the inhibiting effects were due to a combination of ellagic 
acid derivatives in T. bellerica fruit extract. Ellagic acid enriched extracts from Terminalia species 
could be a good source of growth inhibitory compounds suppressing virulence factors in P. 
aeruginosa and other bacteria. 
According to our literature survey the roots of T. brownii are reported to be used for treatment of 
allergy in African traditional medicine (Kareru et al., 2007; Kareru et al., 2008; Mosango, 2013), but 
not for bacterial infections. Our results together with those of Mbwambo et al. (2007) indicate now 
that in addition to the stem bark and wood also the roots could be made into decoctions for treatment 
of bacterial infections. Aqueous extracts of the roots of T. brownii have been reported to be toxic to 
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brine shrimp larvae (Mbwambo et al., 2007), however, and therefore care should be taken when using 
decoctions of the roots of this plant. 
 
Stem bark and wood extracts 
We have found that various stem bark extracts of T. brownii gave promising antibacterial 
activities (Table 2 and 3). Methanolic soxhlet and aqueous extracts expressed MIC values of 78.12 
and 156.25 µg/ml, respectively, against M. luteus and were also effective against S. aureus giving 
MIC values of 156.25 – 312.50 µg/ml against this bacterium (Table 3). Moreover, also an ethyl 
acetate extract of the stem bark gave good effects against P. aeruginosa (IZ: 26 mm) (Table 2). Our 
results are in agreement with Abd alla et al. (2013), Machumi et al. (2013) and Mbwambo et al. 
(2007), who found that various extracts of the stem bark of T. brownii give good antibacterial 
activities. In accordance with our results, Mbwambo et al. (2007) found that especially aqueous 
extracts of the stem bark of T. brownii give promising antimicrobial effects. Therefore the chemical 
composition of aqueous extracts of T. brownii stem bark should be investigated in depth. To the best 
of our knowledge there exists only one investigation on antimicrobial compounds in T. brownii stem 
bark. Machumi et al. (2013) demonstrated antimicrobial ellagic acid derivatives and pentacyclic 
triterpenoids in ethyl acetate extracts of T. brownii stem bark. Decoctions of the stem bark of T. 
brownii are used for diarrhoea and wounds among a plethora of other uses (Machumi et al., 2013; 
Neuwinger, 2000) and these uses are now justified by our results. Moreover, aqueous and methanol 
extracts show little or no cytotoxicity (Mbwambo et al., 2007; Yamauchi et al., 2016). 
We found that ethyl acetate and methanolic soxhlet extracts of the stem wood showed good 
growth inhibitory effects against M. luteus and S. epidermidis (Table 3). Our results are in agreement 
with Muddathir and Mitsunaga (2013) who reported on good antibacterial effects of a stem wood 
extract of T. brownii against Propionibacterium acnes. Mbwambo et al. (2007) found that especially 
aqueous extracts of the stem wood gave good antibacterial effects.  
 
3.1.3. Anogeissus leiocarpus 
We have found that extracts of roots, stem bark and stem wood of A. leiocarpus exert significant 
antibacterial effects, the roots giving the lowest MIC values (Table 2 and 3). Similarly to T. laxiflora 
and T. brownii we found that the antibacterial effects of A. leiocarpus extracts are dose-dependent. 





Table 3  
Minimum inhibitory concentration (MIC) of extracts and their fractions of Terminalia laxiflora, T. brownii and Anogeissus 
leicarpus stem wood, stem bark and roots selected from an initial screening using agar diffusion. MIC values were also 
estimated for punicalagin, ellagic acid and gallic acid which were found to be present in some of the extracts. MIC values 
obtained using microdilution* and agar disc diffusion methods. Results in µg/ml.  
Plant extracts and antibiotics M. luteus S. aureus S. epidermidis P. aeruginosa 
T. laxiflora(S.W.): 
    CHCl3 2500 1250 1250 2500 
EtOAc 312.50* 625.00* 1250* 156.25 
Aqueous fraction 1250* 625.00* 625.00* 312.50 
MeSox 78.12* 156.25* 78.12* 625.00* 
T. laxiflora (S.B.): 
    EtOAc 312.50* 312.50* 625.00* 39.06 
MeSox 78.12 78.12 78.12 312.50* 
T. laxiflora (R): 
    HH2O 39.06 39.06 39.06 39.06 
MeSox 39.06 39.06 39.06 39.06 
acetone 39.06 39.06 39.06 39.06 
EtOAc 39.06* 39.06 39.06* 39.06 
T. brownii (S.W.): 
    EtOAc 156.25* 625.00* 1250* 312.50* 
MeSox 312.50* 312.50* 156.25 312.50 
T. brownii (S.B.): 
    Aqueous fraction 156.25 312.50* 1250* 1250* 
MeSox 78.12* 156.25 156.25* 156.25 
T. brownii (R): 
    HH2O 39.06 78.12 39.06 39.06 
MeSox 39.06* 39.06 39.06 39.06 
acetone 39.06* 39.06 39.06 312.50 
EtOAc 39.06* 39.06 78.12* 156.25 
T. brownii MeSox (R):       
Sephadex LH-20 EtOH wash NT 93.75* NT 187.50* 
A. leiocarpus (S.B.): 
    EtOAc 625.00* 625.00* 312.50* 39.06 
Aqueous fraction 78.12 312.5 2500* 39.06 
MeSox 39.06 39.06 312.50* 625.00* 
A. leiocarpus (S.W.): 
     MeSox 78.12* 156.25 625.00* 1250* 
A. leiocarpus (R): 
    HH2O 39.06 2500 1250 78.12 
MeSox 39.06 39.06 39.06 39.06 
acetone 39.06 78.12 39.06 312.50 








Plant extracts and antibiotics M. luteus S. aureus S. epidermidis P. aeruginosa 
Pure compounds:     
Punicalagin  NT 125.00* NT 500.00* 
Ellagic acid NT 125.00* NT 250.00* 
Gallic acid  NT 500.00* NT 250.00* 
Antibiotics:  
    Ampicillin 0.976* 0.488* 0.976* NT 
Gentamycin NT NT NT 62.50* 
Tetracycline 0.488* 0.031* 0.976* 125.00* 
Penicillin 0.061* 1.950* 0.061* NT 
MIC as mean of triplicates; S.W., stem wood; S.B., stem bark; R, roots. MeSox, methanolic soxhlet extract; HH2O, decoction; EtOAc, ethyl acetate 
extract; CHCl3, Chloroform extract; NT, not tested. The most promising results indicated in bold.  
 
Root extracts 
In agreement with some earlier investigations (Mann et al., 2008b; Ogundiya et al., 2006; Taiwo et al., 
1999), we found that a methanolic soxhlet root extract of A. leiocarpus gave highly promising 
antibacterial effects, expressing MIC values of 39.06 µg/ml against all investigated bacteria (Table 3) 
and large inhibition zones of 36 and 28 mm, respectively, against M. luteus and S. epidermidis (Table 
2). We found that this methanolic root extract is rich in flavonoids such as ampelopsin, aromadendrin, 
methyltaxifolin and its isomer as well as taxifolin and the stilbenes pinosylvin and methylpinosylvin 
(Table 5, Fig. 3, 5 and 8). The mentioned flavonoids and stilbenes have not been characterized earlier 
in the roots of A. leiocarpus. Moreover, we found several ellagic acid derivatives including di-methyl 
ellagic acid and its glucoside and xyloside in this extract (see chapter 3.2.3. for more information on 
the chemistry of A. leiocarpus roots). The excellent antibacterial effects of the methanolic soxhlet root 
extract might be due to some of the mentioned compounds.  
Some of the flavonoids and related compounds we have found to be present in the roots of A. 
leiocarpus have been shown to exert promising antibacterial effects. Ampelopsin A and F gave some 
antibacterial effects (MIC 100-200 µg/ml) against Streptococcus mutans (Yim et al., 2010). Taxifolin 
was found to inhibit the growth of Streptococcus sobrinus, a bacterium common in dental plaques 
(Kuspradini et al., 2009). It is thought that the stereochemistry at C2 and C3 positions govern the 
antimicrobial potency of the flavanol taxifolin as well as in general for flavanones and flavan-3-ols 
(Cushnie and Lamb, 2011; Xu et al., 2013). Also, the position of hydroxyl and methyl moieties in 
flavonoids have been thought to be important for their antibacterial activity and hydroxylation at C2 in 
A ring and C3 in C ring has been found to increase their antimicrobial activity (Alvarez et al., 2004; 
Boulos et al., 2013; Cushnie and Lamb, 2011; Otsuka et al., 2008). Flavonoids could be powerful new 
antibacterial tools since they have been found to act synergistically with antibiotics and to suppress 
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bacterial virulence. The most antimicrobial flavonoid to date is Panduratin A which has given a MIC 
of 0.06 – 2 µg/ml against S. aureus (Cushnie and Lamb, 2011). Antibacterial flavonoids might have 
many cellular targets, rather than just one specific site of action as was thought previously. Flavonoids 
bind to proteins and thus their antimicrobial effects might be related to inactivation of microbial 
adhesins, cell envelope transport proteins and enzymes. Lipophilic flavonoids may disrupt microbial 
membranes (Kumar and Pandey, 2013). 
Of the stilbenes we have found in A. leiocarpus roots, pinosylvin has been demonstrated to 
possess potent bactericidal activity which was higher than that shown by resveratrol (Silva et al., 
2015a). Pinosylvin is included in the constitutive defense of plants against microorganisms and has 
been found to be especially effective as an antifungal compound against wood-destroying fungi 
(Hovelstad et al., 2006). Stilbenes are powerful antibacterial compounds since they act on bacterial 
membranes to interrupt their functions such as permeability and efflux actions (Silva et al., 2015a).To 
the best of our knowledge the other stilbene compound we have found in A. leiocarpus roots, 
methylpinosylvin, has not been subjected to antimicrobial testing to date. The good antibacterial 
effects we have found for the methanol root extract of A. leiocarpus could be due partly to the 
mentioned stilbenes. The antibacterial effects of methylpinosylvin should be elucidated. 
We found that also ethyl acetate and acetone extracts of the roots of A. leiocarpus gave 
significant growth inhibitory results against M. luteus and S. epidermidis (MIC 39.06) and some 
inhibitory effects against P. aeruginosa (312.50 µg/ml) (Table 2 and 3). Moreover, the decoctions of 
the roots demonstrated promising antibacterial activity against P. aeruginosa, M. luteus and S. aureus 
giving MIC values of 39.06 – 78.12  µg/ml (Table 3). These low MIC values correlate well with the 
agar diffusion results of the decoction, expressing large inhibition zones against P. aeruginosa and M. 
luteus (Table 2). 
The traditional uses of the roots of A. leiocarpus as antibacterial infusions and decoctions for 
acute respiratory tract infections (Rajpoot and Singh, 2014), as antibacterial chewing sticks 
(Gbadamosi and Ogunsuyi, 2014) as well as for treatment of wounds (Mann et al., 2008b) are now 
justified by our results. Our results warrant further research into isolation of antimicrobial flavonoids 
and stilbenes from A. leiocarpus roots. A. leiocarpus roots have not been explored sufficiently for new 
antimicrobially active compounds. 
 
Stem bark extracts 
We found that methanolic soxhlet, aqueous and ethyl acetate extracts of the stem bark expressed 
promising antibacterial effects (Table 2 and 3). Nonpolar extracts, such as chloroform and petroleum 
ether extracts, expressed just slight antibacterial effects (Table 2). The best effects were obtained with 
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ethyl acetate and aqueous extracts giving low MIC value of 39.06 µg/ml against P. aeruginosa and 
methanolic soxhlet extracts against S. aureus and M. luteus (Table 3). These results are in agreement 
with the investigations of Mann et   .ʼ  (2008b, 2009, 2010, 201 )     M    (2012), who found that 
stem bark extracts of A. leiocarpus give broad-range antimicrobial effects against Gram-positive and 
Gram-negative bacteria. 
We found that the highly antibacterial ethyl acetate extract of the stem bark of A. leiocarpus is 
enriched in ellagitannins. In addition it contains some condensed tannins such as epigallocatechin 
gallate as well as some gallotannins (Table 5, Fig. 4, See paragraph 3.2.4. for details on chemistry). 
Therefore the good antibacterial activity of this extract could be due to its polyphenols. Recently, 
polyphenols including epigallocatechin have been drawing a great interest for their antibacterial 
potential against Gram-negative MDR bacteria (Betts and Wareham, 2014; Gordon and Wareham, 
2010). In the presence of metal ions, polyphenols have been thought to function as pro-oxidants 
leading to increased production of H2O2 and formation of a free hydroxyl radical promoting outer 
membrane disruption and lysis in Escherichia coli and Klebsiella pneumoniae (Arakawa et al., 2004). 
These findings warrant further studies on the mode of action of polyphenols in combinations with 
other plant derived antimicrobials as well as with conventional antibiotics against human pathogenic 
bacteria (Daglia, 2012). 
The powdered stem bark of A. leiocarpus is used for wounds, sores, cysts and as cough 
medicine in African traditional medicine (Mann et al., 2008b) and these uses are in agreement with 
our results on promising antibacterial activities of stem bark extracts of this plant. 
 
Stem wood extracts 
We report, in agreement with Akande and Hayashi (1998), that extracts of Anogeissus 
leiocarpus stem wood give antibacterial effects. Methanolic soxhlet extracts and aqueous fractions 
were especially active against M. luteus and S. aureus giving MIC values of 78.12 and 156.25 µg/ml, 
respectively, and large inhibition zones from 21-26 mm against all the investigated bacterial strains 
(Table 2 and 3). This indicates that polar compounds, such as ellagitannins could be the antibacterially 
active compounds in these extracts. Interestingly, the chloroform soluble extracts of the stem wood 
gave significant antibacterial effects against P. aeruginosa (IZ: 28 mm, Table 2), but were just slightly 
active against the Gram-positive bacterial strains, indicating that some more nonpolar compounds in 
A. leiocarpus stem wood could be effective inhibitors of Gram-negative bacteria. A petroleum ether 
extract of the stem wood gave very good growth inhibitory activity against S. epidermidis (IZ: 30 mm) 
and indicates that stem wood preparations mixed with animal fat could be used topically as ointments 
for treatment of bacterial infections on the skin. Triterpenes and some triterpene glycosides have been 
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found in the stem bark of A. leiocarpus (Chaabi et al., 2008) and triterpenoidal fractions of stem bark 
have been found to give good antibacterial activity (Mann et al., 2009). Triterpenoids might be 
responsible for the antibacterial effects we have observed for the more nonpolar extracts of the stem 
wood of A. leiocarpus. Rajpoot and Singh (2014) found some antibacterial triterpenoids from the stem 
of A. leiocarpus. 
Our results support the use of whole twigs of A. leiocarpus as chewing sticks (Dweek, 1996). 
Tannins in these sticks might be the active ingredients and they do not need to be digested but can 
exert their effects directly by binding to harmful bacteria in the mouth. Staphylococci have been found 
to cause tonsillitis in the mouth in immunocompromised individuals, and our results thus confirms 
that chewing sticks of A. leiocarpus could be used to treat this condition. Moreover, the high content 
of ellagic acid derivatives in A. leiocarpus also might contribute to inhibit pathogenic bacteria in the 
mouth since ellagic acid isolated from Chinese gall, Gala chinensis, has been found to effectively 
inhibit the growth of Streptococcus species (Loo et al., 2010). 
 
3.2. HPLC-DAD and UHPLC/Q-TOF MS results 
Extracts expressing promising antibacterial activity where subjected to phytochemical investigations, 
with special emphasis on characterization of their ellagitannin and flavonoid composition. Ethyl 
acetate extracts of the root of T. laxiflora and methanolic soxhlet extracts of the root of T. brownii as 
well as methanolic root and ethyl acetate stem bark extracts of A. leiocarpus were found to contain 
ellagitannins, ellagic acid derivatives, flavonoids, stilbenes and phenolic acids. Many of the identified 
compounds have not been presented before in Terminalia laxiflora, T. brownii and A. leiocarpus. In 
addition a number of unknown ellagitannins are presented. Negative ESI-MS was found to be 
favourable for detection of ellagitannins in the extracts and was used for flavonoids and stilbenes as 
well 
 
3.2.1. Terminalia laxiflora root 
Our phytochemical analysis of an ethyl acetate extract of the root of T. laxiflora resulted in the 
identification of eighteen ellagitannins and two ellagic acid glycosides (Table 4, Fig. 1). This result is 
in agreement with Ekong and Idemudia (1967) who reported on ellagic acid derivatives in the 
heartwood of T. laxiflora and with Muddathir et al. (2013) who found ellagitannins in methanol 
extracts of T. laxiflora stem wood. To the best of our knowledge the polyhydroxy-lactone diterpene 
laxiflorin is the only compound known to date in the roots of T. laxiflora (Ekong and Idemudia, 1967) 




We report here for the first time on the occurrence of the ellagitannins corilagin (3) (tR 12.52 
min, [M-H]
-
 ion at m/z 633.0750) and its more polar isomer (2) (tR 8.56 min, [M-H]
-
 ion at m/z 
633.0743) as well as punicalagin (4) (tR 15.25 min, [M-H]
-
 ion at m/z 1083.1541) (Table 4, Fig. 1, 5). 
We found that flavogallonic acid dilactone and terchebulin were absent from the roots of T. laxiflora, 
even though these ellagitannins are reported to occur in the stem wood of this plant (Muddathir et al., 
2013). Corilagin and its isomer as well as punicalagin are present in high concentrations in T. laxiflora 
roots at 6.7, 20.4 and 13.0 % peak area, respectively, at 220 nm (Table 4, Fig.1). Corilagin and 
punicalagin along with their derivatives have been found in various organs of other Terminalia 
species, such as in the roots of Terminalia macroptera (Pham, 2014; Silva et al., 2000; Silva et al., 
2012) and the fruits of Terminalia horrida, T. bellerica and T. chebula (Miyasaki et al., 2013; 
Pfundstein et al., 2010). Corilagin is a fairly rare ellagitannin, and has originally been found from 
Caesalpinia coriaria (Leguminosae) (Pham, 2014). In addition to the mentioned ellagitannins we 
identified two unknown ellagitannins (7 and 8) in the roots of T. laxiflora at tR 27.88 and 29.73 min, 
giving [M-H]
-
 molecular ions of 817.4026 and 817.4033, respectively (Table 4, Fig. 1). For these 
ellagitannins we could not find references in literature, and therefore NMR analysis should be made to 
confirm their chemical identity. A number of other ellagitannins were also identified (Table 4, Fig. 1) 
according to their characteristic UV absorbance maxima showing three peaks of maximum 
absorbance, but the molecular masses were not detected for these. 
Ellagic acid-xylopyranoside (5) and methyl ellagic acid xyloside (6) giving [M-H]
-
 molecular 
ions of 433.0407 and 447.0568, respectively, have not been presented before in the roots of T. 
laxiflora (Table 4, Fig. 1, 5). Trimethyl- and tetramethyl ellagic acid have been reported earlier in the 
heartwood of T. laxiflora (Ekong and Idemudia, 1967). Mono- and dimethyl ellagic acid as well as 
gallagic acids which are building blocks of ellagitannins are known from many species of Terminalia 
(Machumi et al., 2013; Pfundstein et al., 2010; Silva et al., 2015b). 
 
3.2.2. Terminalia brownii root 
From quadrupole time of flight mass-spectrometric and HPLC-DAD analysis, eleven ellagitannins, 
two gallotannins, gallic acid and seven ellagic acid derivatives along with pure ellagic acid were 
characterized from a methanolic soxhlet extract of the root of T. brownii (Table 4, Fig. 2). To the best 
of our knowledge there is only one previous investigation on ellagitannins in the stem bark of T. 
brownii (Yamauchi et al., 2016), but there are no previous reports on the ellagitannin composition of 
the root. Therefore, our research has focused especially on ellagitannins in the root part of this plant, 
and the [M-H]
-
 molecular ions for nine ellagitannins are presented in Table 4. We characterized the 
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ellagitannin methyl-(S)-flavogallonate (3) (tR 12.63, [M-H]
- 
molecular ion at m/z 483.0795) and its 
more polar isomer (2) (tR 8.64, [M-H]
- 
molecular ion at m/z 483.0811) (Fig. 2, 5) from a root extract 
of T. brownii. Methyl-(S)-flavogallonate has been identified previously in the fruits of Terminalia 
chebula, T. bellerica and T. horrida (Pfundstein et al., 2010) as well as in Terminalia myriocarpa 
leaves (Marzouk et al., 2002). The other ellagitannins present in the roots of T. brownii showed [M-
H]
-
 molecular ions ranging from m/z 456.9961-817.3999, two of the structures being isomers 
(negative ions at 577.1369 and 577.1320) showing the same retention time of 35.75 min (Table 4). 
Consequently, further studies using NMR are required to determine their chemical structures. It has 
been discovered that ellagitannins with the same exact mass may have several isomeric structures 
(Pfundstein et al., 2010). 
We identified seven glycosidic derivatives of ellagic acid in the roots of T. brownii. Di-methyl-ellagic 
acid-di-xyloside (4) (tR 14.82, [M-H]
- 
molecular ion at m/z 595.0950 and MS/MS fragment ion at m/z 
463.0537 which corresponded to the loss of 132 from the molecular ion, the MW of xylose), ellagic 
acid glucuronide (6a) (tR 17.85, [M-H]
- 
molecular ion at m/z 477.0651), methyl ellagic acid 
glucuronide (6b) (tR 17.85, [M-H]
- 
molecular ion at m/z: 491.0829), ellagic acid xylopyranoside (7) 
(tR 18.27, [M-H]
- 
molecular ion at m/z 433.0409) and methyl ellagic acid xyloside (8) (tR 19.39, [M-
H]
- 
molecular ion at m/z 447.0569) were identified for the first time from the roots of T. brownii 
(Table 4, Fig. 2, 5). The last two mentioned ellagic acid glycosides (7 and 8) occur also in the root of 
T. laxiflora (Table 4). Ellagic acid glucuronides have not to the best of our knowledge been previously 
identified in Terminalia spp.. Xylose based glycosides of mono- and dimethyl ellagic acids are known 
from the fruits of Terminalia bellerica, T. horrida and T. chebula (Pfundstein et al., 2010; Sarabhai et 
al., 2013) as well as from the stem bark of Terminalia superba (Kuete et al., 2010). Recently, ellagic 
acid and several ellagic acid derivatives, among them 3-O-methylellag c  c  , 3,3′-di-O-methylellagic 
acid, ellagic acid 4-O-α-L-rhamnopyranoside     3,3′, -tri-O-methylellagic acid have been found in 
the stem bark of Terminalia brownii (Machumi et al., 2013; Yamauchi et al., 2016). 
Along with gallic acid (1) (tR 1.74, MW: 170.0213) we identified a gallotannin in the roots of T. 
brownii (tR 38.98, [M-H]
- 
molecular ion at m/z 553.1732) (Table 4, Fig. 2). To the best of our 
knowledge there are no previous reports on gallotannins in T. brownii. 
 
3.2.3. Anogeissus leiocarpus root 
To the best of our knowledge mass spectrometric analysis has not been conducted before on 
compounds present in the the root of A. leiocarpus. Therefore a methanolic soxhlet extract was 
analyzed for its phenolic compounds using HPLC-DAD and UHPLC/Q-TOF MS. A total of twenty-
four compounds were identified (Table 5, Fig. 3). Among these compounds eight ellagic acid 
26 
 
derivatives, two phenolic acids (gallic and protocatechuic acid), two stilbenes and five flavonoids 
were detected, and some of them have not previously been found in the roots of A. leiocarpus. 
Previously reported phenolic acids in A. leiocarpus include chebulagic, chebulinic, gentisic and 
protocatechuic acid (Arbab, 2014). 
We report here on the occurrence of the flavonols aromadendrin syn. dihydrokaempferol (3) 
([M-H]
- 
molecular ion at m/z 288.0000), ampelopsin (5) ([M-H]
- 
molecular ion at m/z 319.1417), 
taxifolin (7) ([M-H]
- 
molecular ion at m/z 303.0365), methyltaxifolin (6a) ([M-H]
- 
molecular ion at 
m/z 317.0678) and its isomer (6b) ([M-H]
- 
molecular ion at m/z 317.0676) in the roots of A. 
leiocarpus (Table 5, Fig. 3, 5 and 8). Previously, eight flavonoids such as 4H-1-Benzopyran-4-one, 7-
[(6-deoxy-α-Lmannopyranosyl)oxy]-5-hydroxy-2-(4-hydroxy-3-methoxyphenyl), catechin, quercetin, 
isoquercetin, rutin, vitexin and kaempferol have been reported in A. leiocarpus leaves (Arbab, 2014). 
In addition, we identified the stilbenes, pinosylvin syn. trans-3,5-dihydroxystilbene (12) ([M-H]
- 
molecular ion at m/z 211.1339) and methylpinosylvin syn. 3,5-dimethyl-cis-stilbene (15) ([M-H]
- 
molecular ion at m/z 225.0373) for the first time in the roots of Anogeissus leiocarpus (Table 5, Fig. 3, 
5 and 8). Pinosylvin is a well known constituent in pine species such as heartwood of Pinus sylvestris 
and needles of P. densiflora (Lee et al., 2005) and its occurrence has been reported to be restricted to 
the genus Pinus (Dinelli et al., 2006). Stilbenes in general are reported to be common in the heartwood 
of the plant families Pinaceae, Myrtaceae and Moraceae. In Combretaceae (order Myrtales) several 
stilbenes, such as the combretastatins in Combretum (Pettit et al.ʼ  1987, 1988, 1989) and resveratrol 
and its glycosides in Terminalia sericea (Joseph et al., 2007) have been reported. Pterostilbene, a 
cytotoxic dimethylated derivative of resveratrol, was characterized from Anogeissus acuminata stem 
bark (Rimando et al., 1994) but has not been reported in A. leiocarpus. 
Moreover, we identified four ellagic acid derivatives from the roots of A. leiocarpus, such as di-
methyl ellagic acid glucoside (8) ([M-H ]
-
 molecular ion at m/z 491.0843), di-methylellagic acid 
xylopyranoside (10) ([M-H]
- 
molecular ion at m/z 461.0739) and its aglycone (11) ([M-H]
- 
molecular 
ion at m/z 329.0318) and an acetylated ellagic acid derivative (13) ([M-H]
- 
molecular ion at m/z 
343.0477) (Table 5).  
3,3´-Di-O-methyl ellagic acid glucoside has been identified in Terminalia paniculata (Row and 
Rao, 1962) and 3,3´-Di-O-methyl-ellagic acid xyloside in T. horrida, T. arjuna and T. bellerica fruits 
(Pfundstein et al., 2010) as well as in the stem bark of Anogeissus leiocarpus (Hubert et al., 2014). 
In addition to the above mentioned compounds we identified the gallotannin di-galloyl-β-D-
glucose (4) ([M-H]
- 
molecular ion at m/z 483.0808, MW 484.0846) in the roots of A. leiocarpus 
(Table 5). This gallotannin has not been identified earlier in A. leiocarpus. 
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Table 4  
 
HPLC-DAD and UHPLC/Q-TOF MS data of ellagitannins, ellagic acid derivatives and gallotannins in the roots of Terminalia brownii and T. laxiflora.  
Terminalia laxiflora;  











UVλ absorbtion max.  
from HPLC-DAD  
Peak area 
 (%)  
Monogalloylglucose C13H16O10 1,01  
331,0000 332,0738 216, 276 0,4322 















 216, 258, 380 4,5748 
Corilagin derivative 
 















 210, 254, 382 0,5800 
Trigalloylglucose  C27H24O18 10,95   




















 216, 256, 380 1,4657 
Corilagin C27H22O18  12,52 4,42 633,0750 634,0798 216, 256, 380 6,6912 




 218, 275 0,2469 




 218, 263, 380 0,6119 
Punicalagin C48H28O30










 256, 380 0,3108 
ellagic acid xylopyranoside  C19H14O12 18,03 7,88 433,0407 434,0480 210, 255, 380 2,3893 
methyl ellagic acid xyloside  C20H16O12 20,48 8,23 447,0568 448,0636 254, 368 8,8803 
ellagitannin 
 
27,88 12,79 817,4026  220, 264, 398 0,9001 





Terminalia brownii;  









Exact mass  
(calc.) 
UVλ absorbtion max.  
from HPLC-DAD  
Peak area  
(%)  
gallic acid C7H6O5





 216, 258, 381 1,2368 
ellagitannin  
 





 216, 258, 382 1,4888 
Isomer of Methyl-(S)-flavogallonate 
 





 216, 272, 380 1,5824 
Methyl-(S)-flavogallonate C22H12O13  12,63 8,60 483,0795 484,0273 216, 257, 381 2,2440 
Di-methyl-ellagic acid-di-xyloside 
 
14,82 10,39 595,0950  254, 362 1,3049 
ellagitannin  
 
15,36 10,50 609,1088  216, 256, 381 12,8987 
Ellagic acid glucuronide 
 
17,85 11,63 477,0651  254, 368 0,6982 
Methyl ellagic acid glucuronide 
 
17,85 11,89 491,0829  254, 368 
 
Ellagic acid-xylopyranoside C19H14O12 18,27 12,10 433,0409 434,0480 256, 380 3,2320 
Methyl ellagic acid xyloside  C20H16O12 19,39 12,42 447,0569 448,0636 254, 362 1,5295 
Ellagic acid  C14H6O8 20,36 12,57 300,9983 302,0060 254, 366 10,8179 
ellagic acid derivative  
 
22,33 13,19 343,0466  248, 368 1,6932 
ellagitannin 
 
28,31 14,67 725,4141  210, 262, 370 1,1540 
ellagitannin 
 
28,93 14,98 817,4003  219, 254, 363 0,8172 
acetylated ellagic acid derivative 
 
33,94 16,10 343,0498  222, 348, 375 1,4695 
ellagitannin 
 
35,75 16,43 577,1369  214, 254, 372 1,7649 
ellagitannin  
 




37,95 16,90 817,3999  216, 250, 372 0,2569 
gallotannin   38,98 17,22 553,1732  218, 278 0,8886 
         Rt (min), retention times obtained from HPLC-DAD and UHPLC-DAD; [M-H]-, base ion at negative mode. The % peak area was obtained from HPLC-DAD chromatograms at 220 nm.
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3.2.4. Anogeissus leiocarpus stem bark 
Our chemical profiling of the ethyl acetate extract of the stem bark of A. leiocarpus revealed the 
presence of seventeen compounds including gallic acid, the flavonol ampelopsin, six ellagic acid 
derivatives and six unknown ellagitannins (Fig. 4). 
Three unknown ellagitannins were identified at m/z 453.1062, 833.4009 and 725.4177 as shown 
in Table 5. The ellagitannins castalagin (MW 934), flavogallonic acid, punicalagin and terchebulin 
have been identified in butanol and aqueous extracts of the stem bark of A. leiocarpus, but castalagin 
was found to be absent from an ethyl acetate extract (Shuaibu et al., 2008). This explains why we did 
not detect castalagin in the ethyl acetate extract of A. leiocarpus stem bark. 
We report for the first time on the occurrence of the condensed tannin epigallocatechin gallate 
(at m/z 457.0768) in the stem bark of A. leiocarpus (Table 5). Previously, (-)-epigallocatechin and (+)-
gallocatechin have been characterized in the stem bark of A. leiocarpus (Hubert et al., 2014). 
Moreover, we identified two ellagic acid derivatives in the stem bark as di-methylellagic acid 
xylopyranoside and di-methyl ellagic acid. These compounds were also present in the roots of A. 
leiocarpus (Fig. 3) and have been mentioned before to occur in A.leiocarpus stem bark (Adigun et al., 
2000; Chaabi et al., 2008). Other ellagic acid derivatives which have been reported in the stem bark of 
A. leiocarpus include 3,3´,4´tri-O-methylflavellagic acid, 3,4,3´-tri-O-methylflavellagic acid 4´-O-
glucopyranoside and 3,3´,3´tri-O-methylflavellagic acid- β-D-glucoside (Adigun et al., 200; Chaabi et 




In our search for antibacterially active extracts of the African medicinal plants Terminalia 
laxiflora, Terminalia brownii and Anogeissus leiocarpus we can confirm that polar methanolic soxhlet 
and ethyl acetate extracts as well as decoctions of the roots and stem bark give promising growth 
inhibitory effects against Pseudomonas aeruginosa and Staphylococcus aureus. The lowest recorded 
MIC values of 39.06 µg/ml are in accordance with other reports on promising antimicrobial potential 
of African species of Terminalia and Anogeissus (Conrad et al., 2001). 
We found that antibacterial root and stem bark extracts of T. brownii, T. laxiflora and A. 
leiocarpus are rich in ellagitannins, ellagic acid derivatives, flavonoids and stilbenes. The 
ellagitannins corilagin and its isomer as well as punicalagin have not been reported previously in the 
roots of T. laxiflora. Likewise, the ellagitannin methyl-(S)-flavogallonate and its isomer are reported 
for the first time in the roots of T. brownii. These ellagitannins, along with several unknown 
ellagitannins, occur in high concentrations in the studied Terminalia species and might be the 
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principal antibacterial compounds in polar extracts of these species, such as traditionally made 
decoctions. The probability of finding new ellagitannin structures in species of Terminalia and 
Anogeissus is high, since ellagitannins are diverse to their chemical structure. 
Antibacterial effects of Terminalia spp. and Anogeissus spp. extracts might be due to a 
combination of ellagitannins and other compounds in the extracts (Miyasaki et al., 2013) and when 
these compounds are separated from each other their antimicrobial effects might decrease. Our study 
demonstrates that the pure compounds punicalagin, ellagic acid and gallic acid, which are present in 
the extracts of the studied plants, are less antimicrobial than the crude extracts. Moreover, a Sephadex 
LH-20 fraction of T. brownii roots, enriched with methyl-(S)-flavogallonate and its isomer, was found 
to give a higher MIC (93–187 µg/ml) compared to the crude extract (39 µg/ml) and the pure 
compounds (125–500 µg/ml). This implies that the compounds in the crude root extract of T. brownii 
act synergistically with each other.  
Our results justify the traditional uses of hot water decoctions of Terminalia laxiflora, T. 
brownii and Anogeissus leiocarpus roots and stem bark in Africa for treatment of bacterial infections 
related to wounds and diarrhoea. Especially in remote regions in African countries lacking Western 
clinics and where conventional antibiotics can be difficult to find or too expensive to purchase there 
would be a need for new antimicrobial standardized extracts containing a known composition of 
active compounds (Eloff and McGaw, 2006). Further work should be performed in detail on the 
phytochemistry of various species of Terminalia and Anogeissus used in traditional medicine. 
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Table 5  
HPLC-DAD and UHPLC/ Q-TOF MS data of flavonoids, stilbenes, ellagitannins and ellagic acid derivatives in the roots and stem bark of A. leiocarpus.  
Anogeissus leiocarpus;  









Exact mass  
(calc.) 
UV absorbtion max.  
from HPLC-DAD  
Peak area 
(%)  
Gallic acid  C7H6O5  1,71 1,24 169,0145 170,0213 216, 272 3,2040 





 214, 256, 376 1,3816 
Dihydrokaempferol (syn. Aromadendrin) C15H12O6 10,47 3,80 288,0000 288,0630 210, 288 0,9248 
Di-galloyl-β-D-glucose C20H20O14 11,43 4,51 483,0808 484,0846 216, 276 1,7803 
Ampelopsin (syn. Dihydromyricetin) C15H12O8 12,66 4,84 319,1417 320,0528 210, 292 5,4055 
Methyltaxifolin (syn.  (+)-Dihydroisorhamnetin) C16H14O7 13,44 5,50 317,0678 318,0735 210,294 2,3772 
Isomer of Methyltaxifolin  C16H14O7 14,82 5,98 317,0676 318,0735 210, 230, 288 2,6073 
Taxifolin (syn. Dihydroquercetin) C15H12O7 17,05 6,45 303,0365 304,0579 210, 230, 290 5,9525 
ellagic acid derivative    18,65 
  
 254, 380 1,7024 
ellagic acid derivative    19,20 
  
 248, 370 1,7194 
ellagic acid derivative    20,06 
  
 254, 362 1,5205 
Di-methyl ellagic acid glucoside  C22H20O13 21,17 7,75 491,0843 492,0897 254, 368 2,1967 
Pentagalloylglucose C41H32O26 22,24  
939,6700 940,1170 218, 284 0,6405 
Di-methyl ellagic acid-xylopyranoside C21H18O12 24,67 9,65 461,0739 462,0792 246, 368 11,1780 










 222, 250, 369 0,7353 










 248, 374 
 
Pinosylvin syn.trans-3,5-Dihydroxystilbene C14H12O2 32,92 12,05 211,1339 212,0834 218, 308, 320 0,8785 
Acetylated ellagic acid derivative 
 
34,29 12,80 343,0477  222, 248, 370 1,8107 
Ellagic acid derivative 
 
36,39 13,43 359,0430  246, 380 5,2358 
4`-Methylpinosylvin syn. 3,5 dimethyl-cis-stilbene C15H14O2 45,65 17,94 225,0373 226,0990 216, 218, 308, 318 19,0662 
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Rt (min), retention times obtained from HPLC-DAD and UHPLC; [M-H]-, base ion at negative mode. The % peak area was obtained from HPLC-DAD chromatograms at 220 nm.
Anogeissus leiocarpus;  









Exact mass  
(calc.) 
UVλ absorbtion max. 




  1,68 0,95 169,0139 170,0213 216, 272 5,6432 
ellagitannin  
 
8,48 8,32 453,1062  217, 256, 374 3,3271 
Ampelopsin C15H12O8 11,70 4,72 319,1417 320,0528 210, 292 0,6719 










 210, 256, 366 1,4000 
Gallotannin 
 
16,70 11,34 441,0852  216, 270 1,3627 









 210, 254, 362 0,4205 
Di-methyl-ellagic acid xylopyranoside C21H18O12 20,49 13,06 461,0766 462,0792 254, 369 3,0833 
ellagic acid derivative 
 
23,91 13,92 673,1030  246, 370 2,1831 
ellagitannin 
 
26,92 14,47 833,4009  210, 248, 370 1,3134 
Di-methyl ellagic acid  C16H10O8 28,78 14,89 329,0000 330,0372 248, 376 6,2357 
ellagic acid derivative 
 
30,92 15,56 613,0858  248, 378 0,5120 
ellagitannin 
 
33,85 16,49 725,4177  219, 248, 370 2,4310 
ellagic acid derivative   35,76 16,72 359,0436  246, 381 2,9099 
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Figure captures for this research paper: 
Fig. 1. HPLC fingerprint at 220 nm of an antibacterial (MIC 39.06 µg/ml against all tested bacteria) ethyl acetate extract of 
the roots of Terminalia laxiflora. Gallic acid (1) and the ellagitannins corilagin (3) and its isomer (2) as well as punicalagin 
(4) occur in high concentrations in this extract. Ellagic acid -xylopyranoside (5) and methyl ellagic acid xyloside (6) are 
reported for the first time in the root of T. laxiflora. Two large-molecular, nonpolar ellagitannins (7 and 8) were present at 
27.886 and 29.733 min. UV absorbtion maxima are indicated for compounds 2, 3, 4 and 5.   
 
Fig. 2. HPLC fingerprint at 270 nm of an antibacterial (MIC 39.06 µg/ml) soxhlet methanol extract of the roots of 
Terminalia brownii. Gallic acid (1) and eleven ellagitannins were identified in this extract, among them the possible 
isomer of methyl-(S)-flavogallonate (2), methyl-S-flavogallonate (3) and an unknown ellaggitannin (5). In addition this 
extract contains di-methyl-ellagic acid-di-xyloside (4), ellagic acid glucuronide (6a) and its methylated derivative (6b), 
ellagic acid xylopyranoside (7), methyl ellagic acid xyloside (8), ellagic acid (9), an ellagic acid derivative (10) and an 
acetylated ellagic acid derivative (13). 11-12 and 14-15 are ellagitannins. 16 is a gallotannin. UV absorbtion maxima are 
indicated for compounds 3, 4, 7 and 8.  
 
Fig. 3. HPLC fingerprint at 270 nm of an antibacterial methanolic soxhlet extract of the roots of Anogeissus leiocarpus. 
This extract contains the flavonoids aromadendrin (3), ampelopsin (5), methyltaxifolin (6a) and its isomer (6b) and 
taxifolin (7). In addition this extract contains the phenolic acids gallic acid (1) and protocatechuic acid (2). Among 
gallotannins, Di-galloyl-β-D-glucose (4) and penta-galloyl-glucose (9) were detected.  Several ellagic acid deriavtives, 
including di-methyl ellagic acid glucoside (8), di- methylellagic acid -xylopyranoside (10), di-methyl-ellagic acid (11), an 
acetylated ellagic acid derivative (13) and an ellagic acid derivative (14) were identified. Two stilbenes, pinosylvin (12) 
and methylpinosylvin (15) were identified for the first time from the roots of A. leiocarpus. UV absorbtion maxima are 
indicated for compounds 5, 7, 12 and 15.   
 
Fig. 4. HPLC fingerprint at 270 nm of an antibacterial ethylacetate extract of the stem bark of Anogeissus leiocarpus. This 
extract contains the gallic acid (1), ampelopsin (3), epigallocatechin gallate (4), di- methyl ellagic acid xylopyranoside (9), 
ellagic acid derivatives (8a, 13, 15) and di- methyl ellagic acid (12) along with six unknown ellagitannins (2, 5, 6, 8b, 11 
and 14) and a gallotannin (7). UV absorbtion maxima are indicated for compounds 2, 9, 12 and 14.  
 
Fig. 5. Ellagitannins, ellagic acid derivatives, flavonoids and stilbenes found in this investigation in roots of T. laxiflora*, 
T. brownii ** and stem bark and roots of A. leiocarpus***. 
 
Fig. 6. Concentration dependent inhibition of T. laxiflora root decoction against M. luteus. Results obtained with an agar 
diffusion method.  
 
Fig. 7. Concentration dependent inhibition of a wood ethyl acetate extract of T.laxiflora against S. aureus. Results obtained 
with a microplate method.  
 
Fig. 8. Mass spectra of a) pinosylvin and b) taxifolin present in the roots of Anogeissus leiocarpus. 
 
















